| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.00098 | 1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.0006 | 1 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.00048 | 1 |
| mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.00036 | 1 |